-
Anuh Pharma Analyst Review 2027: Profit Up 47% on Flat Sales and a Near Debt-Free Book
- November 19, 2026
- Posted by: Ankit Jaiswal
- Category: Market
No Comments
Anuh Pharma kept Q2 FY27 revenue flat at ₹185.24 crore but grew profit 47% to ₹11.21 crore on better margins. With no brokerage coverage, we review the API business, first-half trends, the low valuation against pharma peers, the debt-free balance sheet and the risks for 2027.